Gardasil high rates of adverse effects

[Guest guest]

http://snipurl.com/eii29 [semper Vita, NZ]New US report shows that Gardasil involved in far higher rates of adverse effects than meningococcal vaccineMarch 25, 2009 by Brendan MaloneA new report, issued in February, by the centralized federal Vaccine Adverse Events Reporting System in the United States, has compared the anti-HPV vaccine Garasil, with the Menactra (meningococcal) vaccine, and it has found that Gardasil is associated with a far high rate of serious adverse effects than Menactra is.Here is a summary of some of the report’s important findings…-    Compared to Menactra, receipt of Gardasil is associated with at least twice as many Emergency Room visit reports; 4 times more Death reports; 5 times more “Did Not Recover” reports; and 7 times more “Disabled” reports.-    Compared to Menactra, receipt of Gardasil is associated with all of the reports of Blood Clots. All 23 reports of Blood Clots following Gardasil occurred when Gardasil was given alone without any other vaccines.-    Compared to Menactra, receipt of Gardasil is associated with at least 4 times as many Cardiac Arrest reports. All 9 reports of Cardiac Arrest following Gardasil occurred when Gardasil was given alone without any other vaccines.-    Compared to Menactra, receipt of Gardasil is associated with at least 15 times as many Stroke reports. 16 reports of Stroke following Gardasil occurred when Gardasil was given alone.And here is the basic summary from that report:A rough analysis of adverse events reported to VAERS following receipt of Gardasil and/or Menactra vaccines through November 30, 2008 indicate that Gardasil is involved in a much higher number of serious adverse health events than Menactra.Although Gardasil is given in a three-shot series and only one dose of Menactra is given, Menactra is given to both boys and girls while Gardasil is given only to girls. It is unusual for there to be such a big discrepancy between two vaccines used in similar populations involving serious and relatively rare life threatening adverse events and autoimmune disorders such as death, blood clots, cardiac arrest, lupus, thrombosis, stroke, and vasculitis.Fainting, which has been attributed by doctors and health officials as “fear” of needles in teenage girls is reported six times as often (and Syncope is reported three times as often) after receipt of Gardasil than Menactra even though Menactra is also given to girls in the same age group.In pre-licensure clinical trials, Gardasil was only tested in fewer than 1200 girls 16 years and younger.Through November 30, 2008, in girls 16 or younger, there were reports of 9 deaths; 3 blood clots; 4 cardiac arrests; 9 cases of lupus; 6 strokes; and 2 cases of vasculitis developing after receipt of Gardasil. The report makes the following recommendations:1.    The FDA should further investigate reports of serious health problems and deaths following Gardasil vaccination; review the accuracy of information about adverse events contained in product manufacturer inserts; and inform physicians and parents about all serious health problems that have been reported to VAERS after Gardasil vaccination2.    The CDC should re-investigate VAERS reports of serious health problems and deaths after Gardasil vaccination; consider the need to withdraw the recommendation that all girls between the ages of 9 and 26 should receive Gardasil vaccine; and issue a warning that, when a serious adverse event occurs after Gardasil vaccination, no further Gardasil shots should be given3.    Physicians in the fields of pediatrics and obstetrics/gynecology should fully inform patients and parents about all reported Gardasil adverse events and refrain from re-vaccinating those who experience serious health problems following Gardasil vaccination4.    Merck and the NIH should separately conduct studies into the biological mechanisms for Gardasil vaccine injury and death and define them for physicians and the public so:(a) biological high risk factors can be identified to facilitate informed medical decision making; (b) pathological profiles can be developed to confirm Gardasil-induced brain and immune system dysfunction and death; © healing therapies to moderate Gardasil-induced brain and immune system dysfunction can be developed; and (d) Merck can improve the safety of Gardasil5.    Congress should investigate the fast-tracking of Gardasil vaccine without adequate long-term safety studies in American pre-adolescent and teenage girls between ages 9 and16 and the safety and effectiveness of Gardasil vaccine in all age groups.So far I have seen nothing reported in the NZ media about this new report - yet I would have thought that it would have been something that NZ parents should be made aware of.You can read the full report here =====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.